Existing co-morbidity indices and haemoglobin predict penile cancer outcomes in young patients
Argus, L. Clark, J Parnham, Arie S Lau, Maurice W Sangar, Vijay K
Argus, L.
Clark, J
Parnham, Arie S
Lau, Maurice W
Sangar, Vijay K
Citations
Altmetric:
Abstract
Aim: Penile cancer is rarer in young patients, resulting in paucity of literature on outcomes. This study aims to identify prognostic factors for 3-year penile cancer-speci?c survival (3 yr-PCSS) in young patients.
Method: Supra-network MDT records for 924 patients from 2008-2018 were assessed, >45-year olds were excluded. Demographics, co-morbidity scores, haemoglobin, pathohistology and 3 yr-PCSS were collected. Data underwent Chi2, Kaplan-Meier, Cox-regression and multivariate analysis to identify statistical significance between variables and 3 yr-PCSS.
Result: 40 patients with penile naders cell carcinoma were identi?ed, median age 41. 3 yr-PCSS was 85%. Significant associations with 3 yr-PCSS included existing co-morbidity indices, haemoglobin, TNM-staging, lymphovascular and perineural invasion. Patients with ACE score 2 were 16.7x more likely to die of penile cancer in 3 yrs than those <2, Charlson comorbidity index were 2.5x more likely to die of penile cancer in 3 yrs than those <3, and POSSUM score ? 2.9 were 2.2x more likely to die of penile cancer in 3 yrs than those <2.9. Those with haemoglobin <13 g/dL were 19.7x more likely to die of penile cancer in 3 yrs than those ?13 g/dL.
Conclusion: This study demonstrates existing co-morbidity indices and haemoglobin have statistically Significant associations with 3 yr-PCSS. These therefore hold prognostic potential and could be used fpr identification of high risk patients
Affiliation
Description
Date
2020
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Argus L, Clark J, Parnham AS, Lau MW, Sangar VK. Existing co-morbidity indices and haemoglobin predict penile cancer outcomes in young patients. British Journal of Surgery. 2020;107:20-.